These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24284410)

  • 41. Progress towards achieving hepatitis B control in the Cook Islands, Niue, Tokelau, and Kiribati.
    Patel MK; Wannemuehler K; Tairi R; Tutai R; Moturi E; Tabwaia B; Nikuata AB; Etuale MF; Mokoia G
    Vaccine; 2016 Aug; 34(36):4298-303. PubMed ID: 27402565
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How to control highly endemic hepatitis B in Asia.
    Shan S; Cui F; Jia J
    Liver Int; 2018 Feb; 38 Suppl 1():122-125. PubMed ID: 29427490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia.
    Cheah BC; Davies J; Singh GR; Wood N; Jackson K; Littlejohn M; Davison B; McIntyre P; Locarnini S; Davis JS; Tong SYC
    Vaccine; 2018 Jun; 36(24):3533-3540. PubMed ID: 29735323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Results from nationwide hepatitis B serosurvey in Cambodia using simple and rapid laboratory test: implications for National Immunization Program.
    Soeung SC; Rani M; Huong V; Sarath S; Kimly C; Kohei T
    Am J Trop Med Hyg; 2009 Aug; 81(2):252-7. PubMed ID: 19635879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers.
    Poovorawan Y; Chongsrisawat V; Theamboonlers A; Srinivasa K; Hutagalung Y; Bock HL; Hoet B
    J Infect Dis; 2009 Jul; 200(1):33-8. PubMed ID: 19473096
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis B virus in the Lao People's Democratic Republic: a cross sectional serosurvey in different cohorts.
    Black AP; Nouanthong P; Nanthavong N; Souvannaso C; Vilivong K; Jutavijittum P; Samountry B; Lütteke N; Hübschen JM; Goossens S; Quet F; Buisson Y; Muller CP
    BMC Infect Dis; 2014 Aug; 14():457. PubMed ID: 25149478
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An epidemiological serosurvey of hepatitis B virus shows evidence of declining prevalence due to hepatitis B vaccination in central China.
    Yonghao G; Jin X; Jun L; Pumei D; Ying Y; Xiuhong F; Yanyang Z; Wanshen G
    Int J Infect Dis; 2015 Nov; 40():75-80. PubMed ID: 26456567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China.
    Miao N; Zheng H; Sun X; Zhang G; Wang F
    Sci Rep; 2020 Oct; 10(1):18155. PubMed ID: 33097788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparative analyze on hepatitis B seroepidemiological surveys among population aged 1-29 years in different epidemic regions of China in 1992 and 2014].
    Wang FZ; Zhang GM; Shen LP; Zheng H; Wang F; Miao N; Yuan QL; Sun XJ; Bi SL; Liang XF; Wang HQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):462-468. PubMed ID: 28592086
    [No Abstract]   [Full Text] [Related]  

  • 51. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
    Fortuin M; Chotard J; Jack AD; Maine NP; Mendy M; Hall AJ; Inskip HM; George MO; Whittle HC
    Lancet; 1993 May; 341(8853):1129-31. PubMed ID: 8097813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Observational study of vaccine effectiveness 20 years after the introduction of universal hepatitis B vaccination in Tunisia.
    Ben Hadj M; Bouguerra H; Saffar F; Chelly S; Hechaichi A; Talmoudi K; Bahrini A; Chouki T; Hazgui O; Hannachi N; Letaief H; Bellali H; Bahri O; Ben-Alaya-Bouafif N
    Vaccine; 2018 Sep; 36(39):5858-5864. PubMed ID: 30145100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis B vaccination in Burkina Faso: prevalence of HBsAg carriage and immune response in children in the western region.
    Sanou AM; Ilboudo AK; Meda CZ; Togozia A; Coulibaly A; Cisse A; Sagna T; Kania D; Tarnagda Z
    J Infect Dev Ctries; 2018 Nov; 12(11):1002-1008. PubMed ID: 32012131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization.
    Wen WH; Chen HL; Ni YH; Hsu HY; Kao JH; Hu FC; Chang MH
    Hepatology; 2011 Feb; 53(2):429-36. PubMed ID: 21274864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Primary prevention by hepatitis B vaccine on liver cancer in high incidence area of China].
    Wang YT; Chen TY; Zhu J; Jiao YC; Qu CF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Apr; 52(4):402-408. PubMed ID: 29614608
    [No Abstract]   [Full Text] [Related]  

  • 56. Prevalence of hepatitis B surface antigen (HBsAg) in a blood donor population born prior to and after implementation of universal HBV vaccination in Shenzhen, China.
    Wang Z; Zeng J; Li T; Zheng X; Xu X; Ye X; Lu L; Zhu W; Yang B; Allain JP; Li C
    BMC Infect Dis; 2016 Sep; 16():498. PubMed ID: 27647214
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the Protection Provided by Hepatitis B Vaccination in India.
    Puliyel J; Naik P; Puliyel A; Agarwal K; Lal V; Kansal N; Nandan D; Tripathi V; Tyagi P; Singh SK; Srivastava R; Sharma U; Sreenivas V
    Indian J Pediatr; 2018 Jul; 85(7):510-516. PubMed ID: 29318526
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Minimization of hepatitis B infection among children in Jiangsu, China, 12years after integration of hepatitis B vaccine into the expanded program on immunization.
    Lin X; Yang J; Lu H; Zhou Y; Zhou G; Wu H; Xu C; Wu Q; Liu J; Chen S; Yang M; Gu G; Hu Y; Zhou YH
    Vaccine; 2016 Dec; 34(51):6458-6463. PubMed ID: 27866767
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis-B virus infection in India: Findings from a nationally representative serosurvey, 2017-18.
    Murhekar MV; Santhosh Kumar M; Kamaraj P; Khan SA; Allam RR; Barde P; Dwibedi B; Kanungo S; Mohan U; Mohanty SS; Roy S; Sagar V; Savargaonkar D; Tandale BV; Topno RK; Girish Kumar CP; Sabarinathan R; Bitragunta S; Grover GS; Lakshmi PVM; Mishra CM; Sadhukhan P; Sahoo PK; Singh SK; Yadav CP; Kumar R; Dutta S; Toteja GS; Gupta N; Mehendale SM;
    Int J Infect Dis; 2020 Nov; 100():455-460. PubMed ID: 32896662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.
    Liang X; Bi S; Yang W; Wang L; Cui G; Cui F; Zhang Y; Liu J; Gong X; Chen Y; Wang F; Zheng H; Wang F; Guo J; Jia Z; Ma J; Wang H; Luo H; Li L; Jin S; Hadler SC; Wang Y
    Vaccine; 2009 Nov; 27(47):6550-7. PubMed ID: 19729084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.